logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
K

Kieren J. Mather

eli lilly and company

57H指数
396论文数
1.6W被引数
收录论文 152
发表时间
logo
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept
errdiabetes, obesity and metabolism
IF0
err2026-01-20
err0
errOAAI
errShobha Bhattachar MS; Lai San Tham PharmD; Beth Tidemann-Miller PhD; Hilda Ibriga PhD; Hongchang Qu PhD; Daniel A. Briere MS; Axel Haupt MD; Kieren J. Mather MD; Edward Pratt MD
err分享
err收藏
Long-acting GIPR agonist LY3537021 reduces body weight and fasting blood glucose in patients with T2D: Preclinical development and phase 1 randomized ascending dose studies长效GIPR激动剂LY3537021可降低2型糖尿病患者的体重和空腹血糖：非临床研究与1期随机递增剂量研究
errMolecular Metabolism
IF6.6
err2025-12-12
err0
errOAAI
errWilliam Roell; Jorge Alsina-Fernandez; Hongchang Qu; Tamer Coskun; Charles Benson; Axel Haupt; Ronan P. Kelly; Libbey O’Farrell; Kyle W. Sloop; James P. Steele; James Ficorilli; Ajit Regmi; Mallikarjuna Rettiganti; Shweta Urva; Kieren J. Mather; Edward Pratt
err分享
err收藏
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trialEloralintide，一种选择性降钙素基因相关肽受体激动剂，用于治疗肥胖：一项为期48周的2期、多中心、双盲、随机、安慰剂对照试验
errThe Lancet
IF97.3
err2025-11-06
err0
PREAI
errLiana K Billings; Stanley Hsia; Harold Bays; Beth Tidemann-Miller; Jessica O’Hagan; Lai San Tham; Annabelle Butler; Christof Kazda; Kieren J Mather; Tamer Coskun
err分享
err收藏
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of conceptEloralintide (LY3841136)，一种新型降钙素基因相关肽受体激动剂用于肥胖症治疗：从发现到临床概念验证
errMolecular Metabolism
IF6.6
err2025-10-16
err0
errOAAI
errDaniel A. Briere; Hongchang Qu; Katherine Lansu; Minxia Michelle He; Julie S. Moyers; Tamer Coskun; Annie Long; Dawn Allen; Libbey O’Farrell; Breanna Bowen; Edward Pratt; Beth Tidemann-Miller; Lai San Tham; Hilda Ibriga; Jorge Alsina-Fernandez; Kieren J. Mather; Axel Haupt; Shobha N. Bhattachar
err分享
err收藏
Mazdutide reduces body weight in adults with overweight or obesity: A high-dose Phase 1 trialMazdutide可降低超重或肥胖成年人的体重：一项高剂量1期临床试验
errdiabetes obesity metabolism
IF0
err2025-08-20
err0
errOAAI
errShobha N. Bhattachar MS; Lai San Tham PhD; Yan Li PhD; Laiyi Chua PhD; Shu Xuan Ng BS; Yuanyuan Tang PhD; Hilda Ibriga PhD; Wei Ni PhD; Sirel Gurbuz MD; Kieren J. Mather MD; Melissa K. Thomas MD
err分享
err收藏
Orforglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist, improves markers of β-cell function and insulin sensitivity in type 2 diabetesOrforglipron，一种口服非肽类胰高血糖素样肽-1受体激动剂，可改善2型糖尿病中β细胞功能和胰岛素敏感性的指标。
errdiabetes obesity metabolism
IF0
err2025-08-14
err0
PREAI
errJulio Rosenstock MD; Deborah A. Robins MS; Kevin L. Duffin PhD; Jonathan M. Wilson PhD; Yanzhu Lin PhD; Hiya Banerjee PhD; Sarah Eyde PhD; Christof Kazda MD; Manige Konig MD; Kieren J. Mather MD
err分享
err收藏
Prevalence of complications and comorbidities associated with obesity: a health insurance claims analysis
errBMC PUBLIC HEALTH
IF3.6
err2025-01-22
err0
errOAAI
errBae, Jay P.; Nelson, David R.; Boye, Kristina S.; Mather, Kieren J.
err分享
err收藏
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysisTirzebatide与semaglutide相比，单位体重减轻对胰岛素敏感性的改善更大: 一项探索性分析
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-01-06
err0
PREAI
errMather, Kieren J.; Mari, Andrea; Weerakkody, Govinda; Heise, Tim; Devries, J. Hans; Urva, Shweta; Coskun, Tamer; Milicevic, Zvonko; Haupt, Axel; Thomas, Melissa K.
err分享
err收藏
Prevalence of complications and co-morbidities in males and females with obesity: Real-world insights from claims data analysis
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-09-11
err1
errOAAI
errBae, Jay P.; Nelson, David R.; Boye, Kristina S.; Mather, Kieren J.
err分享
err收藏
A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-08-27
err4
errOAAI
errKnop, Filip K.; Urva, Shweta; Rettiganti, Mallikarjuna; Benson, Charles T.; Roell, William C.; Mather, Kieren J.; Haupt, Axel; Pratt, Edward John
err分享
err收藏
Orforglipron Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes
errDIABETES
IF7.5
err2024-06-14
err0
PREAI
errRosenstock, Julio; Robins, Deborah A.; Duffin, Kevin L.; Wilson, Jonathan M.; Mather, Kieren J.; Banerjee, Hiya; Lin, Yanzhu; Eyde, Sarah; Kazda, Christof M.; Konig, Manige
err分享
err收藏
Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity
errDIABETES
IF7.5
err2024-06-14
err0
PREAI
errRosenstock, Julio; Coskun, Tamer; Hartman, Mark L.; Lou, Jitong; Wu, Qiwei; Du, Yu; Gurbuz, Sirel; Mather, Kieren J.; Milicevic, Zvonko; Thomas, Melissa K.
err分享
err收藏
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial三激素受体激动剂瑞他肽治疗代谢功能障碍相关的脂肪性肝病: 一项随机2a期试验
errNATURE MEDICINE
IF50
err2024-06-10
err15
errOAAI
errSanyal, Arun J.; Kaplan, Lee M.; Frias, Juan P.; Brouwers, Bram; Wu, Qiwei; Thomas, Melissa K.; Harris, Charles; Schloot, Nanette C.; Du, Yu; Mather, Kieren J.; Haupt, Axel; Hartman, Mark L.
err分享
err收藏
Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2024-05-26
err4
errOAAI
errMather, Kieren J.; Mari, Andrea; Heise, Tim; DeVries, J. Hans; Hua, Ming; Urva, Shweta; Coskun, Tamer; Haupt, Axel; Heine, Robert J.; Pratt, Edward; Thomas, Melissa K.; Milicevic, Zvonko
err分享
err收藏
Improvements in post-challenge lipid response following tirzepatide treatment in patients with type 2 diabetes替西帕德治疗2型糖尿病患者后激发后脂质反应的改善
errDIABETES OBESITY & METABOLISM
IF5.7
err2023-11-21
err3
errOAAI
errMather, Kieren J.; Coskun, Tamer; Pratt, Edward J.; Milicevic, Zvonko; Weerakkody, Govinda; Thomas, Melissa K.; Haupt, Axel; Ruotolo, Giacomo
err分享
err收藏
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2023-09-07
err136
PREAI
errWharton, Sean; Blevins, Thomas; Connery, Lisa; Rosenstock, Julio; Raha, Sohini; Liu, Rong; Ma, Xiaosu; Mather, Kieren J.; Haupt, Axel; Robins, Deborah; Pratt, Edward; Kazda, Christof; Konig, Manige
err分享
err收藏
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
errLANCET
IF88.5
err2023-08-01
err52
PREAI
errFrias, Juan P.; Hsia, Stanley; Eyde, Sarah; Liu, Rong; Ma, Xiaosu; Konig, Manige; Kazda, Christof; Mather, Kieren J.; Haupt, Axel; Pratt, Edward; Robins, Deborah
err分享
err收藏
Selective Collection of Exhaled Breath Condensate for Noninvasive Screening of Breath Glucose
errJOURNAL OF DIABETES SCIENCE AND TECHNOLOGY
IF3.7
err2023-07-04
err2
PREAI
errDesai, Aditya; Tankasala, Divya; Ng, Gabriel P.; Thakkar, Pankti; Hoilett, Orlando S.; Mather, Kieren J.; Linnes, Jacqueline C.
err分享
err收藏
Effect of Orforglipron vs. Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes
errDIABETES
IF7.5
err2023-06-25
err0
PREAI
errFrias, Juan P.; Hsia, Stanley H.; Eyde, Sarah; Liu, Rong; Ma, Xiaosu; Konig, Manige; Kazda, Christof M.; Pratt, Edward J.; Mather, Kieren J.; Haupt, Axel; Robins, Deborah A.
err分享
err收藏
Effect of Oral Nonpeptide GLP-1 Receptor Agonist Orforglipron (LY3502970) in Participants with Obesity or Overweight-A Phase 2 Study
errDIABETES
IF7.5
err2023-06-23
err0
PREAI
errWharton, Sean; Blevins, Thomas; Connery, Lisa B.; Rosenstock, Julio; Raha, Sohini; Mather, Kieren J.; Haupt, Axel; Robins, Deborah A.; Pratt, Edward J.; Kazda, Christof M.; Konig, Manige
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
E
Elizabeth Barrett‐Connor
H 指数: 143 · 论文数: 857
J
John B. Buse
H 指数: 142 · 论文数: 1.1K
Y
Yūji Matsuzawa
H 指数: 141 · 论文数: 1.4K
T
Thomas J. Wang
H 指数: 140 · 论文数: 870
P
Paul W. Franks
H 指数: 136 · 论文数: 944
查看更多